Transformation Capital Leads $39M Series B Round for AI Compliance Platform Ketryx

Ketryx, the AI-powered compliance platform aiding life sciences companies in delivering safer products quickly, has secured a $39 million Series B funding led by Transformation Capital. Existing investors such as Lightspeed Venture Partners, MIT's E14 Fund, Ubiquity Ventures, and 53 Stations also participated in this round, bringing the total funding to over $55 million.

The company's platform aims to address the challenge of balancing innovation with safety and compliance in the life sciences industry. Ketryx automates validation, traceability, and regulatory workflows, offering FDA/EU MDR-ready documentation to expedite product release cycles for its customers, who report up to a 90% reduction in documentation time.

With its platform already used by three of the top five global medtech companies and several Fortune 500 organizations, Ketryx is positioned as a crucial AI infrastructure layer for regulated industries. The funding from Transformation Capital will aid in the company's global expansion, product roadmap acceleration, and rapid hiring in Boston and Austria.